---
title: "Makers Laboratories Ltd (506919) — Share Price, Financials & Analysis"
symbol: "506919"
company: "Makers Laboratories Ltd"
canonical: "https://tapetide.com/stocks/506919"
isin: "INE987A01010"
nse_symbol: "MAKERSL"
bse_code: "506919"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 103.85
generated_at: "2026-09-13T19:17:23.872Z"
---

# Makers Laboratories Ltd (506919)

Canonical page: https://tapetide.com/stocks/506919

## Company

- **NSE Symbol:** MAKERSL
- **BSE Code:** 506919
- **ISIN:** INE987A01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-08-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** makerslabs.com

## About

Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma
formulations.[1]

## Latest Price

- **Price:** ₹185.87
- **Change:** +7.9 (+4.44%)
- **Open:** ₹177.05
- **Day High:** ₹189
- **Day Low:** ₹175.98
- **Previous Close:** ₹177.97
- **Volume:** 4047
- **As Of:** 2026-09-11T09:55:03+00:00

## Key Fundamentals

Observed at 2026-09-11T04:39:51.428885Z.

- **Market Cap:** ₹103.85 Cr
- **Classification:** Microcap
- **P/E (reported):** 9.4
- **P/E (TTM):** 32.16
- **EPS (TTM):** ₹5.78
- **Book Value:** ₹123.59
- **Price to Book:** 1.45
- **Dividend Yield:** 0%
- **ROE:** 6.42%
- **ROCE:** 8.99%
- **Debt to Equity:** 0.12
- **Revenue (yearly):** ₹142.3 Cr
- **Net Income:** ₹7.9 Cr
- **EBITDA:** ₹16.4 Cr
- **52-Week High:** ₹236
- **52-Week Low:** ₹150
- **RSI (14):** 57.22

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Rising
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 59.03 | 9% |
| growth | 63.08 | 9% |
| momentum | 92.8 | 12% |
| ownership | 50 | 24% |
| quality | 51.18 | 22% |
| valuation | 54.29 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 49.3% CAGR over last 5 years
- Debtor days have improved from 68.8 to 51.6 days.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of -2.05% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 450.25% | — | -22.76% |
| ebitda margin growth | 26.67% | -24.35% | 373.77% | -29.81% |
| net income growth | 27.78% | -27.52% | 35% | 49% |
| revenue growth | 18.9% | 7.32% | 12% | 15% |
| roce | 31.43% | -22.43% | -668.99% | 7.13% |
| roe | 29.21% | -32.21% | 3.76% | -46.28% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 25.06 | 26.51 | 27.81 | 29.59 | 29.57 | 27.69 | 33.9 | 35 | 34.17 | 35.67 | 35.75 | 42.77 |
| Expenses | 24.86 | 26.31 | 26.95 | 27.78 | 27.38 | 26.38 | 30.81 | 31.99 | 31.89 | 31.51 | 30.47 | 35.81 |
| Operating Profit | 0.2 | 0.2 | 0.86 | 1.81 | 2.19 | 1.31 | 3.09 | 3.01 | 2.28 | 4.16 | 5.28 | 6.96 |
| OPM % | 0.8 | 0.75 | 3.09 | 6.12 | 7.41 | 4.73 | 9.12 | 8.6 | 6.67 | 11.66 | 14.77 | 16.27 |
| Other Income | 0.41 | 0.37 | 0.43 | -0.51 | 10.63 | 0.87 | 0.1 | 0.27 | 0.36 | 0.33 | 0.76 | 0.61 |
| Interest | 0.49 | 0.53 | 0.52 | 0.49 | 0.43 | 0.19 | 0.18 | 0.18 | 0.22 | 0.2 | 0.17 | 0.15 |
| Depreciation | 1.13 | 1.16 | 1.15 | 1.28 | 1.29 | 1.31 | 0.9 | 1.12 | 1.13 | 1.14 | 1.13 | 1.13 |
| Profit before tax | -1.01 | -1.12 | -0.38 | -0.47 | 11.1 | 0.68 | 2.11 | 1.98 | 1.29 | 3.15 | 4.74 | 6.29 |
| Tax % | 10.89 | -4.46 | 152.63 | 48.94 | 11.98 | 60.29 | 24.64 | 34.85 | 42.64 | 27.94 | 24.89 | 27.03 |
| Net Profit | -1.13 | -1.06 | -0.97 | -0.7 | 9.76 | 0.27 | 1.58 | 1.29 | 0.74 | 2.27 | 3.56 | 4.59 |
| EPS in Rs | -2.27 | -2.61 | -2.19 | -1.66 | 14.95 | -0.51 | -0.08 | 0.75 | -0.2 | 1.59 | 1.85 | 2.54 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 69 | 127 | 101 | 104 | 121 | 141 | 148 |
| Expenses | 60 | 108 | 98 | 103 | 112 | 126 | 130 |
| Operating Profit | 8 | 19 | 3 | 1 | 9 | 15 | 19 |
| OPM % | 12 | 15 | 3.3 | 1.1 | 7 | 11 | 13 |
| Other Income | 1 | 3 | 2 | 2 | 11 | 2 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 5 | 4 | 4 | 5 | 5 | 5 | 5 |
| Profit before tax | 3 | 16 | -1 | -4 | 13 | 11 | 15 |
| Tax % | 50 | 25 | 161 | 23 | 19 | 30 | — |
| Net Profit | 1 | 12 | -2 | -5 | 11 | 8 | 11 |
| EPS in Rs | -0.56 | 8.44 | -8.05 | -10.61 | 12.69 | 3.98 | 5.78 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 6 | 6 | 6 | 6 |
| Reserves | 49 | 55 | 63 | 57 | 65 | 67 |
| Borrowings | 21 | 23 | 17 | 22 | 8 | 9 |
| Other Liabilities | 62 | 62 | 66 | 76 | 70 | 85 |
| Total Liabilities | 136 | 144 | 152 | 161 | 148 | 167 |
| Fixed Assets | 71 | 68 | 85 | 87 | 74 | 71 |
| CWIP | 0 | 9 | 0 | 0 | 1 | 4 |
| Investments | 2 | 0 | 0 | 3 | 0 | 12 |
| Other Assets | 63 | 66 | 67 | 71 | 73 | 81 |
| Total Assets | 136 | 144 | 152 | 161 | 148 | 167 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 18 | -9 | 1 | -4 | 14 |
| Cash from Investing Activity | 0 | -22 | 1 | -7 | 20 | -15 |
| Cash from Financing Activity | 0 | 0 | 6 | 6 | -16 | 0 |
| Net Cash Flow | 0 | -3 | -2 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 9 | -21 | -6 | 11 | 11 |
| CFO/OP | 0 | 128 | -185 | 232 | -20 | 118 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 88 | 39 | 72 | 70 | 85 | 52 |
| Inventory Days | 344 | 166 | 281 | 227 | 230 | 250 |
| Days Payable | 182 | 38 | 91 | 112 | 79 | 110 |
| Cash Conversion Cycle | 250 | 167 | 262 | 185 | 236 | 192 |
| Working Capital Days | 112 | 61 | 113 | 97 | 140 | 106 |
| ROCE % | — | 15 | 1 | -2 | 4 | 9 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.39% | 0% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 29.63% | 29.65% | 29.93% | 30.54% | 30.86% | 30.67% | 30.9% | 31.01% | 30.98% | 31.2% | 31.47% | 31.72% |
| Others | 8.7% | 9.08% | 8.4% | 7.8% | 7.48% | 7.67% | 7.43% | 7.33% | 7.36% | 7.14% | 6.86% | 6.62% |
| No. of Shareholders | 4283 | 4179 | 4176 | 4090 | 4008 | 4031 | 4135 | 4073 | 4026 | 3926 | 3801 | 3745 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 3 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 186.63 | Sell |
| EMA (10) | 186.5 | Sell |
| SMA (20) | 188.19 | Sell |
| EMA (20) | 184 | Buy |
| SMA (50) | 167.45 | Buy |
| EMA (50) | 172.88 | Buy |
| SMA (100) | 160.03 | Buy |
| EMA (100) | 163.25 | Buy |
| SMA (200) | 146.73 | Buy |
| EMA (200) | 154.77 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.88 | Neutral |
| MACD (12,26,9) | 5.08 | Sell |
| Stochastic (14,3,3) | 11.88 | Buy |
| ADX (14) | 30.75 | Buy |
| Williams %R (14) | -83.52 | Buy |
| ATR (14) | 13.4 | High Volatility |
| ROC (12) | -13.34 | Sell |
| Stoch RSI (14) | 14.96 | Buy |
| UO (7,14,28) | 41.92 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2fb60e9-e31c-44f3-b264-bb27a048b0b9.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=153ba587-76d7-4a17-a15b-9578689fe588.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0b5a1d2-6511-41c7-81c1-5ad00ee5b06d.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ba230f3-5736-4215-ab50-dce03149d8e6.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7c15ba8-d6d4-4bed-969f-fe91addcccfd.pdf) |
| 2026-08-07 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e73cb8-606c-4549-9c18-d54291a73a90.pdf) |
| 2026-08-07 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be8bd1f-a935-46a0-b7c9-9441768699e7.pdf) |
| 2026-07-23 | [Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 1St Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1fc6974-f50d-4f4b-985c-89c74651ef1d.pdf) |
| 2026-07-13 | [Intimation To Shareholders Regarding Weblink Of Annual Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9acf102f-5001-466b-9824-f80b0a3bf315.pdf) |
| 2026-07-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7875d3fa-1bd6-48e6-b843-ef416763ec31.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Standalone And Consolidated Financial Results For Q1FY27](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a2c0871-f4b7-47fa-b4e4-df94c4f67c3b.pdf) |
| 2026-05-26 | [Standalone And Consolidated Results For FY 25-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b78d0a0b-c960-4f23-befa-c7c8a5f641de.pdf) |
| 2026-02-10 | [Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bac4658-fce2-402d-aa1f-e1da8c882a5e.pdf) |
| 2025-11-07 | [Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be40d761-1f32-4b92-ab61-b6d8c65e3270.pdf) |
| 2025-08-08 | [Standalone And Consolidated Unaudited Financial Results For Q1FY26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0343cbb2-a515-45cb-ab91-0b0c4a446d39.pdf) |
| 2025-05-26 | [Standalone And Consolidated Q4FY25 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fc12d6f-8fed-4899-ad9b-297e6e758fe4.pdf) |
| 2025-01-29 | [Standalone And Consolidated Q3FY25 Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa5145d5-b968-4e7f-9d36-31450265c19d.pdf) |
| 2024-10-29 | [Standalone And Consolidated Q2H1FY25 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76bcb92d-e977-4b21-ab06-757ba465247d.pdf) |
| 2024-08-06 | [Standalone And Consolidated Q1FY25 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=980d6cb1-b0cc-4346-b5be-39f9949a3c3b.pdf) |
| 2024-05-23 | [Audited Standalone And Consolidated Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1c289ba-28cf-4905-be71-51c9fb671740.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/23639f90-c91a-4795-876d-4ba033cbee21.pdf) |
| 5 May - Board meeting on 26 May 2026 to consider FY26 audited Q4 and annual results; trading window closed till 28 May 2026. | [Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For 4Th Quarter And Financial Year Ended 31St March, 2026 5 May - Board meeting on 26 May 2026 to consider FY26 audited Q4 and annual results; trading window closed till 28 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b008cb00-1c54-4798-81a4-9ce253dbe9ef.pdf) |
| 21 Jan - Re-lodgement report from RTA for physical share transfers Nov-Dec 2025. | [Re-Lodgement Of Transfer Requests Report - November 2025 And December 2025 21 Jan - Re-lodgement report from RTA for physical share transfers Nov-Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ca238b9-cfed-4546-ad01-f01e9d752358.pdf) |
| 21 Jan - Board meeting on 10 February 2026 to consider Q3 and nine-month unaudited results ended 31 December 2025. | [Board Meeting Intimation for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31St December, 2025 21 Jan - Board meeting on 10 February 2026 to consider Q3 and nine-month unaudited results ended 31 December 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db543650-3301-4df9-9a73-5bfdeb705bad.pdf) |
| 19 Jan - Quarterly investor complaints for quarter ended 31/12/2025: zero received, zero pending, zero unresolved. | [Statement Of Investor Complaints As Per Regulation 13(3) Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended December, 31St 2025. 19 Jan - Quarterly investor complaints for quarter ended 31/12/2025: zero received, zero pending, zero unresolved.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bdeb782-f14f-4626-9c16-acc728310b4f.pdf) |
| 16 Jan - Certificate under SEBI Reg.74(5) for quarter ended Dec 31, 2025; no share certificates dematerialised. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 16 Jan - Certificate under SEBI Reg.74(5) for quarter ended Dec 31, 2025; no share certificates dematerialised.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/011e4b26-dba6-4545-8c35-20b8ee8afc9f.pdf) |
| 14 Nov 2025 - Board approved unaudited standalone results for half-year ended Sep 30, 2025; limited review report dated Nov 14, 2025. | [Board Meeting Outcome for We Hereby Submit The Outcome Of The Board Meeting Held On 14Th November 2025 Pursuant To Regulatin 30 Of SEBI (LODR) 2015 14 Nov 2025 - Board approved unaudited standalone results for half-year ended Sep 30, 2025; limited review report dated Nov 14, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0f47f1d-3e78-4b19-b93c-b906641f1165.pdf) |
| 11 Nov 2025 - Board meeting Nov 14, 2025 to approve unaudited standalone H1 results; trading window closed. | [Board Meeting Intimation for Board Meeting Intimation For Half Yearly Un-Audited Financial Results For The Half Year Ended On September 30, 2025. 11 Nov 2025 - Board meeting Nov 14, 2025 to approve unaudited standalone H1 results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28984ef1-df81-4846-9d2e-f9638f416456.pdf) |
| 10 Feb - Q3 & 9M FY2026 results: consolidated 9M revenue Rs10,484.31L; consolidated 9M PAT Rs125.78L; approved Feb 10, 2026. | [Board Meeting Outcome for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025 10 Feb - Q3 & 9M FY2026 results: consolidated 9M revenue Rs10,484.31L; consolidated 9M PAT Rs125.78L; approved Feb 10, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e4e5f7e-c86a-421a-a0f9-c67c72d265a0.pdf) |
| — | [Closure of Trading Window 16 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf2a36ba-f802-4eb3-a9fa-ac4374e975b8.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8ffbe10-97aa-46e7-b704-17c8ad1b0297.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7768e17c-4f84-448d-ad21-46d868549cb7.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/429c60b6-473f-4ee2-9510-c5d9f4f08e96.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf4af99d-d14e-44ee-9bd5-a91c46920147.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/803cff46-f57d-4938-bf3b-ea78fc2bf553.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28ddfb16-e63c-4f1f-99c2-c10723d612ed.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506919/73730506919.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506919/69013506919.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/506919/5069190320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506919/5069190319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:23.872Z.